Document is current
Any future updates will be listed below
-
Authors
Wu, Stanley Chun Ming
Zhu, Manyu
Chik, Stanley C. C.
Kwok, Maxwell https://orcid.org/0000-0001-5920-9341
Javed, Asif
Law, Laalaa
Chan, Shing
Boheler, Kenneth R.
Liu, Yin Ping
Chan, Godfrey Chi Fung
Poon, Ellen Ngar-Yun https://orcid.org/0000-0002-9280-3681
-
Funding
Funding for this research was provided by:
Health and Medical Research Fund (03143156)
- License Information
-
More Information
Article History
Received: 31 August 2022
Accepted: 18 May 2023
First Online: 25 June 2023
Declarations
:
: Written informed consents were obtained, and the study has been approved by the Combined Internal Review Board of The University of Hong Kong and The Hong Kong West Cluster of Hospital of Hospital Authority. (Title of the approved project: Generation of Mesenchumal Stem Cell for Potential Clinical Use, Approval number: # UW 13-429, Date of Approval: 17 July 2018). The animal study was performed in accordance with the ARRIVE guidelines and was approved by the Committee on the Use of Live Animals in Teaching and Research of the University of Hong Kong. (Title of the approved project: Identification of the optimal source of human mesenchymal stromal cells for the treatment of acute graft-versus-host disease under a clinical-grade ex-vivo culture system, Approval number: 3893-16, Date of approval: 16 Feb 2016).
: Not applicable.
: The authors declare that they have no competing interests.
